Principal Street Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Principal Street Partners, LLC

$555 Million
Q2 2024

A detailed history of Principal Street Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Principal Street Partners, LLC holds 2,381 shares of VRTX stock, worth $1.23 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

2,381

Previous 2,410 1.2%

Holding current value

$1.23 Million

Previous $1.01 Million 10.82%

% of portfolio

0.2%

Previous 0.19%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $11,391 - $14,080	-29 Reduced 1.2%	2,381 $1.12 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $72,161 - $78,956	177 Added 7.93%	2,410 $1.01 Million
Q4 2023 Feb 07, 2024	SELL	$343.0 - $410.68 $34,986 - $41,889	-102 Reduced 4.37%	2,233 $908,000
Q3 2023 Nov 01, 2023	SELL	$338.18 - $362.46 $39,567 - $42,407	-117 Reduced 4.77%	2,335 $811,000
Q2 2023 Aug 21, 2023	SELL	$314.42 - $351.91 $8,803 - $9,853	-28 Reduced 1.13%	2,452 $862,000
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $275,866 - $314,699	-974 Reduced 28.2%	2,480 $781,000
Q4 2022 Feb 15, 2023	SELL	$285.76 - $321.48 $83,156 - $93,550	-291 Reduced 7.77%	3,454 $997,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $41,895 - $46,746	153 Added 4.26%	3,745 $1.09 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $112,545 - $140,131	-479 Reduced 11.77%	3,592 $1.01 Million
Q1 2022 May 05, 2022	SELL	$221.42 - $260.97 $77,718 - $91,600	-351 Reduced 7.94%	4,071 $1.06 Million
Q4 2021 Feb 07, 2022	BUY	$177.01 - $223.45 $283,747 - $358,190	1,603 Added 56.86%	4,422 $971,000
Q3 2021 Nov 10, 2021	SELL	$181.39 - $202.99 $265,373 - $296,974	-1,463 Reduced 34.17%	2,819 $512,000
Q2 2021 Aug 10, 2021	SELL	$187.49 - $221.1 $896,764 - $1.06 Million	-4,783 Reduced 52.76%	4,282 $864,000
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $958,709 - $1.12 Million	4,631 Added 104.44%	9,065 $1.95 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $47,405 - $63,224	229 Added 5.45%	4,434 $1.05 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $38,347 - $45,465	-150 Reduced 3.44%	4,205 $1.14 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $951,751 - $1.25 Million	-4,221 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $200,768 - $249,049	-1,005 Reduced 19.23%	4,221 $1 Million
Q4 2019 Mar 04, 2020	SELL	$166.71 - $223.91 $281,906 - $378,631	-1,691 Reduced 24.45%	5,226 $1.14 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $486,721 - $547,799	2,928 Added 73.4%	6,917 $1.16 Million
Q2 2019 Aug 15, 2019	BUY	$164.61 - $190.37 $71,440 - $82,620	434 Added 12.21%	3,989 $732,000
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $582,060 - $692,158	3,555 New	3,555 $654,000

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

226M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Street Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Principal Street Partners, LLC with notifications on news.

Account

Principal Street Partners, LLC Vertex Pharmaceuticals Inc Transaction History